7th Edition of Neurology World Conference 2027

As populations age, cognitive decline is becoming one of the defining health challenges of our time. A person may lose track of words, struggle with a bill they once paid easily, or ask the same question twice in an afternoon. Spotting these early signs matters because it gives patients and families time to understand what is happening and to act early.

This track focuses on mild cognitive impairment and the many causes of cognitive decline, including Alzheimer's disease, vascular damage, diabetes, hearing loss, depression, and poor sleep. Sessions will cover screening and assessment tools that work in busy clinics, modifiable risk factors, and the evidence behind exercise, diet, and brain training programs. We will also discuss newer disease-modifying treatments, such as the anti-amyloid antibodies lecanemab and donanemab, which can slow decline in people with early Alzheimer's disease.

We invite neurologists, geriatricians, psychiatrists, psychologists, researchers, and care professionals who are helping people stay sharp, safe, and independent.

Topics include:

• Mild cognitive impairment: diagnosis and outcomes
• Early detection and cognitive screening tools
• Vascular and mixed causes of cognitive decline
• Modifiable risk factors and prevention
• Lifestyle and multidomain interventions
• Disease-modifying therapies and their use in practice
• Supporting patients and caregivers
• Digital tools for monitoring cognition

Help us find better ways to protect memory and independence at every stage of life.